← Open Payments lookup

PAUL BROWN: Open Payments

NPI 1831284405 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$898 in 49 payments from 11 companies in 2025. Trend: 2023 $463 · 2024 $595 · 2025 $898

Food & beverage: $898
CompanyPaymentsAmount
ABBVIE INC.28$503
Janssen Biotech, Inc.5$109
Takeda Pharmaceuticals U.S.A., Inc.3$62
PFIZER INC.3$59
Ardelyx, Inc.3$43
GENZYME CORPORATION1$29
Aimmune Therapeutics, Inc.1$21
Novo Nordisk Inc1$20
Lilly USA, LLC1$19
Phathom Pharmaceuticals, Inc.2$18

Products named: LINZESS, SKYRIZI, RINVOQ, TREMFYA, ENTYVIO, VELSIPITY, IBSRELA, MAVYRET.

Industry payments across FL — which companies pay providers there.